The CDTRP Clinical Trials Group (CDTRP-CTG) invites you to join our upcoming virtual clinical trials meeting on July 29th at 3 pm ET, which will discuss clinical trials, COVID-19, and vaccination.

Dr. Ruth Sapir-Pichhadze will share insights from the CO2I2 Trial in a talk entitled:

Patient, Family, and Donor Voices Matter: Lessons Learned from the CO2I2 Trial on Maintaining Engagement and Adherence to the COVID-19 Vaccine Schedule.

Dr. Sapir-Pichhadze will share key insights into strategies for improving vaccine engagement and adherence among transplant populations.

We encourage you to attend and take part in the open discussion that will occur after the presentation. We will discuss broader issues regarding clinical trials and vaccination.

Register now!

CDTRP-CTG expectations for meeting participation:
  1. We expect that all attendees (members and visitors) respect the confidential information presented at the CDTRP-CTG meetings or in subsequent correspondence by not sharing it with non-CDTRP-CTG members unless by explicit agreement with the principal investigator.
  2. We expect attendees to engage in a collegial and respectful fashion in the meeting sessions.
  3. Confidential information means all data, information, activities, ideas, study names/acronyms and concepts relating to critical care research that are proprietary to the CTG member or her/his collaborators, in any format and however disclosed.